MANE Earnings Date: Nov 10, 2026 (Estimated) — Veradermics, Incorporated
NYSE
Updated
When is MANE's next earnings date?
Veradermics, Incorporated (MANE) is expected to report Q3 2026 earnings on Tuesday, November 10, 2026 at 5:30 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.59.
How did MANE do in its last earnings report?
In its most recent report on Aug 11, 2026 (Q2 2026), Veradermics, Incorporated posted EPS of -$0.58 versus the -$0.65 estimate, a beat of 7.9%. Revenue was $0. The stock's 1-day post-earnings move was -1.6%.
How much does MANE stock move after earnings?
MANE beat EPS estimates in 2 of its last 3 reported quarters. Over the last 3 reports the stock moved an average of 4.2% (up or down) in the day after earnings.
About Veradermics, Incorporated
Veradermics, Incorporated functions as a biopharmaceutical enterprise focused on devising pioneering therapeutic interventions for various skin and cosmetic disorders. The company's development pipeline includes treatments for Pattern Hair Loss (PHL), impacting both adult and pediatric demographics. A flagship offering is VDPHL01, an orally administered, non-hormonal medication specifically for chronic hair loss management in both male and female patients with PHL. Furthermore, Veradermics is progressing with VDMN, an innovative dissolvable microarray patch technology employing immunotherapy for common warts. Its research also extends to VDAA for addressing alopecia areata, and VDMC, aimed at molluscum contagiosum. Collectively, the firm's product candidates target conditions such as androgenetic alopecia, common warts, molluscum contagiosum, alopecia areata, and atopic dermatitis. Veradermics caters to healthcare practitioners and clinicians specializing in dermatologic and aesthetic care for patients of all ages, in addition to the wider medical and scientific community engaged in dermatology. Founded in 2019, the company is based in New Haven, Connecticut.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-11 | Q2 2026 | -0.65 | -0.58 | +7.94% | $0 | ✅ Beat | -1.63% | -2.28% | -10.00% |
| 2026-05-12 | Q1 2026 | -0.79 | -1.32 | -67.09% | $0 | ❌ Miss | -3.91% | -7.17% | -14.01% |
| 2026-03-30 | Q4 2025 | -0.66 | -0.62 | +6.06% | $0 | ✅ Beat | -7.14% | -2.61% | +57.33% |
Showing last 3 quarters.